Indication
Pyridoxine-dependent seizure
A pyridoxine-dependent seizure is a manifestation of a rare neurometabolic disorder, most commonly pyridoxine-dependent epilepsy, characterized by recurrent, medically intractable seizures that primarily present in neonates and young infants. Read more about Pyridoxine-dependent seizure
35 drugs 32 manufacturers
Drugs that treat it
Common Pyridoxine-dependent seizure therapies.
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE HCL (pyridoxine HCl (vitamin B6))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA pyridoxine-dependent seizure is a manifestation of a rare neurometabolic disorder, most commonly pyridoxine-dependent epilepsy, characterized by recurrent, medically intractable seizures that primarily present in neonates and young infants.
The condition predominantly affects the central nervous system and is most frequently caused by autosomal recessive mutations in the *ALDH7A1* gene encoding antiquitin.
This deficiency leads to the accumulation of lysine degradation intermediates that chemically inactivate pyridoxal 5'-phosphate, an essential cofactor in central neurotransmitter synthesis such as gamma-aminobutyric acid.
Clinically, these seizures—which often present as prolonged convulsions or status epilepticus—are refractory to standard antiseizure medications but rapidly resolve following the administration of pharmacological doses of pyridoxine.
- rarediseases.org
A pyridoxine-dependent seizure is a manifestation of a rare neurometabolic disorder, most commonly pyridoxine-dependent epilepsy, characterized by recurrent, medically intractable seizures that primarily present in neonates and young infants The condition predominantly affects the central nervous system and is most frequently caused by autosomal recessive mutations in the *ALDH7A1* gene encoding antiquitin This deficiency leads to the accumulation of lysine degradation intermediates that chemica...
- orpha.net
A pyridoxine-dependent seizure is a manifestation of a rare neurometabolic disorder, most commonly pyridoxine-dependent epilepsy, characterized by recurrent, medically intractable seizures that primarily present in neonates and young infants The condition predominantly affects the central nervous system and is most frequently caused by autosomal recessive mutations in the *ALDH7A1* gene encoding antiquitin Clinically, these seizures—which often present as prolonged convulsions or status epilepti...
- medicover-genetics.com
This deficiency leads to the accumulation of lysine degradation intermediates that chemically inactivate pyridoxal 5'-phosphate, an essential cofactor in central neurotransmitter synthesis such as gamma-aminobutyric acid
- nih.gov
Clinically, these seizures—which often present as prolonged convulsions or status epilepticus—are refractory to standard antiseizure medications but rapidly resolve following the administration of pharmacological doses of pyridoxine
Personalize your experience
Follow Pyridoxine-dependent seizure and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.